March 9, 2009 - ProteoTech Inc. announced that both Dr. Alan D. Snow, Chairman, President & CSO, and Dr. Luke Esposito, Director of In Vitro Screening, will present at the 9th International Conference for Alzheimer’s and Parkinson’s Diseases, to be held in Prague, Czech Republic, March 11-15, 2009. On Sunday March 15, Dr. Alan D. Snow will give an oral presentation discussing promising results pertaining to ProteoTech’s current Phase 1A human clinical trial with the small molecule Exebryl-1® for the treatment of mild-to-moderate Alzheimer’s disease. Dr. Snow’s talk is entitled: “Exebryl-1®: A Novel Small Molecule Currently in Human Clinical Trials as a Disease-Modifying Drug for the Treatment of Alzheimer’s Disease.”... [PDF] ProteoTech's Press Release -
Saturday, January 16, 2010
ProteoTech : at the 9th International Conference for Alzheimer's...
March 9, 2009 - ProteoTech Inc. announced that both Dr. Alan D. Snow, Chairman, President & CSO, and Dr. Luke Esposito, Director of In Vitro Screening, will present at the 9th International Conference for Alzheimer’s and Parkinson’s Diseases, to be held in Prague, Czech Republic, March 11-15, 2009. On Sunday March 15, Dr. Alan D. Snow will give an oral presentation discussing promising results pertaining to ProteoTech’s current Phase 1A human clinical trial with the small molecule Exebryl-1® for the treatment of mild-to-moderate Alzheimer’s disease. Dr. Snow’s talk is entitled: “Exebryl-1®: A Novel Small Molecule Currently in Human Clinical Trials as a Disease-Modifying Drug for the Treatment of Alzheimer’s Disease.”... [PDF] ProteoTech's Press Release -
